Skip to Main Content
Back to News

Lobbying Update: $60,000 of BD (BECTON DICKINSON AND COMPANY) lobbying was just disclosed

None

$60,000 of BD (BECTON DICKINSON AND COMPANY) lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"federal budget issues IRA, diagnostics, supply chain, privacy Medicare coverage and reimbursement, diagnostics product shortages related to EPA regulation supply chain, US competitiveness"

You can find more data on corporate lobbying on Quiver Quantitative.

BDX Congressional Stock Trading

Members of Congress have traded $BDX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BDX Insider Trading Activity

BDX insiders have traded $BDX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:

  • RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
  • JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
  • DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 1,666 shares for an estimated $319,607.
  • MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 2 sales selling 1,076 shares for an estimated $235,693.
  • SHANA CAROL NEAL (EVP and Chief People Officer) sold 787 shares for an estimated $188,880
  • BERTRAM L SCOTT sold 700 shares for an estimated $159,593

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BDX Hedge Fund Activity

We have seen 673 institutional investors add shares of BDX stock to their portfolio, and 774 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BDX Analyst Ratings

Wall Street analysts have issued reports on $BDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 06/03/2025
  • Morgan Stanley issued a "Overweight" rating on 05/06/2025
  • Stifel issued a "Buy" rating on 05/02/2025

To track analyst ratings and price targets for BDX, check out Quiver Quantitative's $BDX forecast page.

BDX Price Targets

Multiple analysts have issued price targets for $BDX recently. We have seen 6 analysts offer price targets for $BDX in the last 6 months, with a median target of $210.0.

Here are some recent targets:

  • Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
  • Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
  • Patrick Wood from Morgan Stanley set a target price of $196.0 on 05/06/2025
  • Jason Bednar from Piper Sandler set a target price of $185.0 on 05/02/2025
  • Rick Wise from Stifel set a target price of $224.0 on 05/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles